The DOI matches its Crossref record; 179 of the 179 references it cites were found in a registry or an index.
Antibody response to SARS-CoV-2 infection in humans: A systematic review
Open accessAbstract
Background: Progress in characterising the humoral immune response to Severe Acute Respiratory Syndrome 2 (SARS-CoV-2) has been rapid but areas of uncertainty persist. Assessment of the full range of evidence generated to date to understand the characteristics of the antibody response, its dynamics over time, its determinants and the immunity it confers will have a range of clinical and policy implications for this novel pathogen. This review comprehensively evaluated evidence describing the antibody response to SARS-CoV-2 published from 01/01/2020-26/06/2020. Methods: Systematic review. Keyword-structured searches were carried out in MEDLINE, Embase and COVID-19 Primer. Articles were independently screened on title, abstract and full text by two researchers, with arbitration of disagreements. Data were double-extracted into a pre-designed template, and studies critically appraised using a modified version of the Public Health Ontario Meta-tool for Quality Appraisal of Public Health Evidence (MetaQAT) tool, with resolution of disagreements by consensus. Findings were narratively synthesised. Results: 150 papers were included. Most studies (113 or 75%) were observational in design, were based wholly or primarily on data from hospitalised patients (108, 72%) and had important methodological limitations. Few considered mild or asymptomatic infection. Antibody dynamics were well described in the acute phase, up to around three months from disease onset, but the picture regarding correlates of the antibody response was inconsistent. IgM was consistently detected before IgG in included studies, peaking at weeks two to five and declining over a further three to five weeks post-symptom onset depending on the patient group; IgG peaked around weeks three to seven post-symptom onset then plateaued, generally persisting for at least eight weeks. Neutralising antibodies were detectable within seven to 15 days following disease onset, with levels increasing until days 14–22 before levelling and then decreasing, but titres were lower in those with asymptomatic or clinically mild disease. Specific and potent neutralising antibodies have been isolated from convalescent plasma. Cross-reactivity but limited cross-neutralisation with other human coronaviridae was reported. Evidence for protective immunity in vivo was limited to small, short-term animal studies, showing promising initial results in the immediate recovery phase. Conclusions: Literature on antibody responses to SARS-CoV-2 is of variable quality with considerable heterogeneity of methods, study participants, outcomes measured and assays used. Although acute phase antibody dynamics are well described, longer-term patterns are much less well evidenced. Comprehensive assessment of the role of demographic characteristics and disease severity on antibody responses is needed. Initial findings of low neutralising antibody titres and possible waning of titres over time may have implications for sero-surveillance and disease control policy, although further evidence is needed. The detection of potent neutralising antibodies in convalescent plasma is important in the context of development of therapeutics and vaccines. Due to limitations with the existing evidence base, large, cross-national cohort studies using appropriate statistical analysis and standardised serological assays and clinical classifications should be prioritised.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775
The trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Jackson, L. A., Anderson, E. J., Rouphael, N. G., Roberts, P. C., Makhene, M., Coler, R. N., McCullough, M. P., Chappell, J. D., Denison, M. R., Stevens, L. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022483 · Cited by 3,406
Ferguson, N. M., Laydon, D. J., Nedjati-Gilani, G. L., Imai, N., Ainslie, K. E. C., Baguelin, M., Bhatia, S., Boonyasiri, A., Cucunubá, Z. M., Cuomo-Dannenburg, G., et al. (2020) · Spiral (Imperial College London) · doi:10.25561/77482 · Cited by 3,281
To, K. K.-W., Tsang, O. T.-Y., Leung, W.-S., Tam, A. R., Wu, T.-C., Lung, D. C., Yip, C. C.-Y., Cai, J.-P., Chan, J. M.-C., Chik, T. S.-H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30196-1 · Cited by 3,066
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Long, Q.-X., Tang, X.-J., Shi, Q.-L., Li, Q., Deng, H.-J., Yuan, J., Hu, J.-L., Xu, W., Zhang, Y., Lv, F.-J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0965-6 · Cited by 2,686
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Zhao, J., Yuan, Q., Wang, H., Liu, W., Liao, X., Su, Y., Wang, X., Yuan, J., Li, T., Li, J., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa344 · Cited by 2,607
Folegatti, P. M., Ewer, K. J., Aley, P. K., Angus, B., Becker, S., Belij-Rammerstorfer, S., Bellamy, D., Bibi, S., Bittaye, M., Clutterbuck, E. A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31604-4 · Cited by 2,419
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Sahin, U., Muik, A., Derhovanessian, E., Vogler, I., Kranz, L. M., Vormehr, M., Baum, A., Pascal, K., Quandt, J., Maurus, D., et al. (2020) · Nature · doi:10.1038/s41586-020-2814-7 · Cited by 1,977
Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals
Robbiani, D. F., Gaebler, C., Muecksch, F., Lorenzi, J. C. C., Wang, Z., Cho, A., Agudelo, M., Barnes, C. O., Gazumyan, A., Finkin, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2456-9 · Cited by 1,853
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Ju, B., Zhang, Q., Ge, J., Wang, R., Sun, J., Ge, X., Yu, J., Shan, S., Zhou, B., Song, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2380-z · Cited by 1,667 · cited 1×
“Neutralising ability correlated in particular with competition for the angiotensin converting enzyme - 2 (ACE2) receptor.(70,72,106) Two studies demonstrated a lack of association with affinity,(73,106) although a moderate correlation with binding affinity was reported in one study.”
BackgroundImmunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623
Okba, N. M. A., Müller, M. A., Li, W., Wang, C., GeurtsvanKessel, C. H., Corman, V. M., Lamers, M. M., Sikkema, R. S., de Bruin, E., Chandler, F. D., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200841 · Cited by 1,614
Sex differences in immune responses that underlie COVID-19 disease outcomes
Takahashi, T., Ellingson, M. K., Wong, P., Israelow, B., Lucas, C., Klein, J., Silva, J., Mao, T., Oh, J. E., Tokuyama, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2700-3 · Cited by 1,459
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., et al. (2020) · Cell · doi:10.1016/j.cell.2020.07.012 · Cited by 1,420
Seow, J., Graham, C., Merrick, B., Acors, S., Pickering, S., Steel, K. J. A., Hemmings, O., O’Byrne, A., Kouphou, N., Galao, R. P., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00813-8 · Cited by 1,419
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
Chi, X., Yan, R., Zhang, J., Zhang, G., Zhang, Y., Hao, M., Zhang, Z., Fan, P., Dong, Y., Yang, Y., et al. (2020) · Science · doi:10.1126/science.abc6952 · Cited by 1,385
Impact of sex and gender on COVID-19 outcomes in Europe
Gebhard, C., Regitz-Zagrosek, V., Neuhauser, H. K., Morgan, R., & Klein, S. L. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00304-9 · Cited by 1,306
Rogers, T. F., Zhao, F., Huang, D., Beutler, N., Burns, A., He, W.-T., Limbo, O., Smith, C., Song, G., Woehl, J., et al. (2020) · Science · doi:10.1126/science.abc7520 · Cited by 1,230
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Hansen, J., Baum, A., Pascal, K. E., Russo, V., Giordano, S., Wloga, E., Fulton, B. O., Yan, Y., Koon, K., Patel, K., et al. (2020) · Science · doi:10.1126/science.abd0827 · Cited by 1,210
Cao, Y., Su, B., Guo, X., Sun, W., Deng, Y., Bao, L., Zhu, Q., Zhang, X., Zheng, Y., Geng, C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.025 · Cited by 1,188
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Brouwer, P. J. M., Caniels, T. G., van der Straten, K., Snitselaar, J. L., Aldon, Y., Bangaru, S., Torres, J. L., Okba, N. M. A., Claireaux, M., Kerster, G., et al. (2020) · Science · doi:10.1126/science.abc5902 · Cited by 1,140
Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
Ni, L., Ye, F., Cheng, M.-L., Feng, Y., Deng, Y.-Q., Zhao, H., Wei, P., Ge, J., Gou, M., Li, X., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.04.023 · Cited by 1,063
Huang, A. T., Garcia-Carreras, B., Hitchings, M. D. T., Yang, B., Katzelnick, L. C., Rattigan, S. M., Borgert, B. A., Moreno, C. A., Solomon, B. D., Trimmer-Smith, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18450-4 · Cited by 1,026
Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development
Imai, M., Iwatsuki-Horimoto, K., Hatta, M., Loeber, S., Halfmann, P. J., Nakajima, N., Watanabe, T., Ujie, M., Takahashi, K., Ito, M., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2009799117 · Cited by 1,021
Wu, Y., Wang, F., Shen, C., Peng, W., Li, D., Zhao, C., Li, Z., Li, S., Bi, Y., Yang, Y., et al. (2020) · Science · doi:10.1126/science.abc2241 · Cited by 993
A dynamic COVID-19 immune signature includes associations with poor prognosis
Laing, A. G., Lorenc, A., del Molino del Barrio, I., Das, A., Fish, M., Monin, L., Muñoz-Ruiz, M., McKenzie, D. R., Hayday, T. S., Francos-Quijorna, I., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1038-6 · Cited by 946
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
Lumley, S. F., O’Donnell, D., Stoesser, N. E., Matthews, P. C., Howarth, A., Hatch, S. B., Marsden, B. D., Cox, S., James, T., Warren, F., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2034545 · Cited by 940
Humoral Immune Response to SARS-CoV-2 in Iceland
Gudbjartsson, D. F., Norddahl, G. L., Melsted, P., Gunnarsdottir, K., Holm, H., Eythorsson, E., Arnthorsson, A. O., Helgason, D., Bjarnadottir, K., Ingvarsson, R. F., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2026116 · Cited by 903
Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3541136 · Cited by 898
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans
Ng, K. W., Faulkner, N., Cornish, G. H., Rosa, A., Harvey, R., Hussain, S., Ulferts, R., Earl, C., Wrobel, A. G., Benton, D. J., et al. (2020) · Science · doi:10.1126/science.abe1107 · Cited by 886
Eubank, S., Eckstrand, I., Lewis, B., Venkatramanan, S., Marathe, M., & Barrett, C. L. (2020) · Bulletin of Mathematical Biology · doi:10.1007/s11538-020-00726-x · Cited by 881
Premkumar, L., Segovia-Chumbez, B., Jadi, R., Martinez, D. R., Raut, R., Markmann, A. J., Cornaby, C., Bartelt, L., Weiss, S., Park, Y., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abc8413 · Cited by 868
Antibody tests for identification of current and past infection with SARS‐CoV‐2
Geppert, J., Scandrett, K., Bigio, J., Sulis, G., Hettiarachchi, D., Mathangasinghe, Y., Weeratunga, P., Wickramasinghe, D., Bergman, H., Buckley, S. B., et al. (2022) · LSTM Online Archive (Liverpool School of Tropical Medicine) · Cited by 850
Davies, N. G., Kucharski, A. J., Eggo, R. M., Gimma, A., Edmunds, W. J., Jombart, T., O'Reilly, K., Endo, A., Hellewell, J., Nightingale, E. S., et al. (2020) · The Lancet Public Health · doi:10.1016/s2468-2667(20)30133-x · Cited by 848
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
Jiang, S., Hillyer, C., & Du, L. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.03.007 · Cited by 847
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients
Isho, B., Abe, K. T., Zuo, M., Jamal, A. J., Rathod, B., Wang, J. H., Li, Z., Chao, G., Rojas, O. L., Bang, Y. M., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abe5511 · Cited by 822
SARS-CoV-2 infection protects against rechallenge in rhesus macaques
Chandrashekar, A., Liu, J., Martinot, A. J., McMahan, K., Mercado, N. B., Peter, L., Tostanoski, L. H., Yu, J., Maliga, Z., Nekorchuk, M., et al. (2020) · Science · doi:10.1126/science.abc4776 · Cited by 816
Antibodies in Infants Born to Mothers With COVID-19 Pneumonia
Zeng, H., Xu, C., Fan, J., Tang, Y., Deng, Q., Zhang, W., & Long, X. (2020) · JAMA · doi:10.1001/jama.2020.4861 · Cited by 804
Wu, F., Wang, A., Liu, M., Wang, Q., Chen, J., Xia, S., Ling, Y., Zhang, Y., Xun, J., Lu, L., et al. (2020) · doi:10.1101/2020.03.30.20047365 · Cited by 754
Antibody tests for identification of current and past infection with SARS-CoV-2
Deeks, J. J., Dinnes, J., Takwoingi, Y., Davenport, C., Spijker, R., Taylor-Phillips, S., Adriano, A., Beese, S., Dretzke, J., Ferrante di Ruffano, L., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013652 · Cited by 655
Weisberg, S. P., Connors, T. J., Zhu, Y., Baldwin, M. R., Lin, W.-H., Wontakal, S., Szabo, P. A., Wells, S. B., Dogra, P., Gray, J., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00826-9 · Cited by 548
Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019
Xiang, F., Wang, X., He, X., Peng, Z., Yang, B., Zhang, J., Zhou, Q., Ye, H., Ma, Y., Li, H., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa461 · Cited by 535
Zhang, B., Zhou, X., Zhu, C., Song, Y., Feng, F., Qiu, Y., Feng, J., Jia, Q., Song, Q., Zhu, B., et al. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00157 · Cited by 528
Serum IgA, IgM, and IgG responses in COVID-19
Ma, H., Zeng, W., He, H., Zhao, D., Jiang, D., Zhou, P., Cheng, L., Li, Y., Ma, X., & Jin, T. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0474-z · Cited by 511
Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients
Suthar, M. S., Zimmerman, M. G., Kauffman, R. C., Mantus, G., Linderman, S. L., Hudson, W. H., Vanderheiden, A., Nyhoff, L., Davis, C. W., Adekunle, O., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100040 · Cited by 508
Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients
Sun, B., Feng, Y., Mo, X., Zheng, P., Wang, Q., Li, P., Peng, P., Liu, X., Chen, Z., Huang, H., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1762515 · Cited by 473
Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset
Lou, B., Li, T.-D., Zheng, S.-F., Su, Y.-Y., Li, Z.-Y., Liu, W., Yu, F., Ge, S.-X., Zou, Q.-D., Yuan, Q., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00763-2020 · Cited by 472
Burbelo, P. D., Riedo, F. X., Morishima, C., Rawlings, S., Smith, D., Das, S., Strich, J. R., Chertow, D. S., Davey, R. T., & Cohen, J. I. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa273 · Cited by 471
Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19
Juno, J. A., Tan, H.-X., Lee, W. S., Reynaldi, A., Kelly, H. G., Wragg, K., Esterbauer, R., Kent, H. E., Batten, C. J., Mordant, F. L., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0995-0 · Cited by 437
Lack of Reinfection in Rhesus Macaques Infected with SARS-CoV-2
Bao, L., Deng, W., Gao, H., Xiao, C., Liu, J., Xue, J., Lv, Q., Liu, J., Yu, P., Xu, Y., et al. (2020) · doi:10.1101/2020.03.13.990226 · Cited by 419
Garcia-Basteiro, A. L., Moncunill, G., Tortajada, M., Vidal, M., Guinovart, C., Jiménez, A., Santano, R., Sanz, S., Méndez, S., Llupià, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17318-x · Cited by 408
Self-citationSystemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19
Cervia, C., Nilsson, J., Zurbuchen, Y., Valaperti, A., Schreiner, J., Wolfensberger, A., Raeber, M. E., Adamo, S., Weigang, S., Emmenegger, M., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.10.040 · Cited by 408
Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
Lv, H., Wu, N. C., Tsang, O. T.-Y., Yuan, M., Perera, R. A. P. M., Leung, W. S., So, R. T. Y., Chan, J. M. C., Yip, G. K., Chik, T. S. H., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107725 · Cited by 407
Detection of IgM and IgG antibodies in patients with coronavirus disease 2019
Hou, H., Wang, T., Zhang, B., Luo, Y., Mao, L., Wang, F., Wu, S., & Sun, Z. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1136 · Cited by 398
Wang, X., Guo, X., Xin, Q., Pan, Y., Hu, Y., Li, J., Chu, Y., Feng, Y., & Wang, Q. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa721 · Cited by 359
Kellam, P., & Barclay, W. (2020) · Journal of General Virology · doi:10.1099/jgv.0.001439 · Cited by 351
Self-citationT cell response to SARS-CoV-2 infection in humans: A systematic review
Shrotri, M., van Schalkwyk, M. C. I., Post, N., Eddy, D., Huntley, C., Leeman, D., Rigby, S., Williams, S. V., Bermingham, W. H., Kellam, P., et al. (2021) · PLOS ONE · doi:10.1371/journal.pone.0245532 · Cited by 350
Self-citationRipperger, T. J., Uhrlaub, J. L., Watanabe, M., Wong, R., Castaneda, Y., Pizzato, H. A., Thompson, M. R., Bradshaw, C., Weinkauf, C. C., Bime, C., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.10.004 · Cited by 341
SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic
Ward, H., Atchison, C., Whitaker, M., Ainslie, K. E. C., Elliott, J., Okell, L., Redd, R., Ashby, D., Donnelly, C. A., Barclay, W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21237-w · Cited by 337
Chen, X., Li, R., Pan, Z., Qian, C., Yang, Y., You, R., Zhao, J., Liu, P., Gao, L., Li, Z., et al. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0426-7 · Cited by 332
Zeng, F., Dai, C., Cai, P., Wang, J., Xu, L., Li, J., Hu, G., Wang, Z., Zheng, F., & Wang, L. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25989 · Cited by 330
Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020
Perera, R. A., Mok, C. K., Tsang, O. T., Lv, H., Ko, R. L., Wu, N. C., Yuan, M., Leung, W. S., Chan, J. M., Chik, T. S., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.16.2000421 · Cited by 322
Grzelak, L., Temmam, S., Planchais, C., Demeret, C., Tondeur, L., Huon, C., Guivel-Benhassine, F., Staropoli, I., Chazal, M., Dufloo, J., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abc3103 · Cited by 310
IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study
Padoan, A., Sciacovelli, L., Basso, D., Negrini, D., Zuin, S., Cosma, C., Faggian, D., Matricardi, P., & Plebani, M. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.04.026 · Cited by 309
Kreer, C., Zehner, M., Weber, T., Ercanoglu, M. S., Gieselmann, L., Rohde, C., Halwe, S., Korenkov, M., Schommers, P., Vanshylla, K., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.044 · Cited by 309
The Role of Antibody Testing for SARS-CoV-2: Is There One?
Theel, E. S., Slev, P., Wheeler, S., Couturier, M. R., Wong, S. J., & Kadkhoda, K. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00797-20 · Cited by 305
Qu, J., Wu, C., Li, X., Zhang, G., Jiang, Z., Li, X., Zhu, Q., & Liu, L. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa489 · Cited by 303
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden
Rudberg, A.-S., Havervall, S., Månberg, A., Jernbom Falk, A., Aguilera, K., Ng, H., Gabrielsson, L., Salomonsson, A.-C., Hanke, L., Murrell, B., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18848-0 · Cited by 303
Viral Kinetics and Antibody Responses in Patients with COVID-19
Tan, W., Lu, Y., Zhang, J., Wang, J., Dan, Y., Tan, Z., He, X., Qian, C., Sun, Q., Hu, Q., et al. (2020) · medRxiv · doi:10.1101/2020.03.24.20042382 · Cited by 301
Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019
Jin, Y., Wang, M., Zuo, Z., Fan, C., Ye, F., Cai, Z., Wang, Y., Cui, H., Pan, K., & Xu, A. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.065 · Cited by 298
Robust and Specific Secretory IgA Against SARS-CoV-2 Detected in Human Milk
Fox, A., Marino, J., Amanat, F., Krammer, F., Hahn-Holbrook, J., Zolla-Pazner, S., & Powell, R. L. (2020) · iScience · doi:10.1016/j.isci.2020.101735 · Cited by 292
Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel
Adams, E. R., Ainsworth, M., Anand, R., Andersson, M. I., Auckland, K., Baillie, J. K., Barnes, E., Beer, S., Bell, J. I., Berry, T., et al. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15927.1 · Cited by 278
Yongchen, Z., Shen, H., Wang, X., Shi, X., Li, Y., Yan, J., Chen, Y., & Gu, B. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1756699 · Cited by 266
Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19
Li, K., Huang, B., Wu, M., Zhong, A., Li, L., Cai, Y., Wang, Z., Wu, L., Zhu, M., Li, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19943-y · Cited by 260
Profile of specific antibodies to SARS-CoV-2: The first report
Xiao, A. T., Gao, C., & Zhang, S. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.012 · Cited by 245
The clinical course and its correlated immune status in COVID-19 pneumonia
He, R., Lu, Z., Zhang, L., Fan, T., Xiong, R., Shen, X., Feng, H., Meng, H., Lin, W., Jiang, W., et al. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104361 · Cited by 241
Zhang, T., Cui, X., Zhao, X., Wang, J., Zheng, J., Zheng, G., Guo, W., Cai, C., He, S., & Xu, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25795 · Cited by 230
The impact of sex and gender on immunotherapy outcomes
Klein, S. L., & Morgan, R. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00301-y · Cited by 213
Lynch, K. L., Whitman, J. D., Lacanienta, N. P., Beckerdite, E. W., Kastner, S. A., Shy, B. R., Goldgof, G. M., Levine, A. G., Bapat, S. P., Stramer, S. L., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa979 · Cited by 212
Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike
Prévost, J., Gasser, R., Beaudoin-Bussières, G., Richard, J., Duerr, R., Laumaea, A., Anand, S. P., Goyette, G., Benlarbi, M., Ding, S., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100126 · Cited by 206
High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients
Chen, Y., Tong, X., Wang, J., Huang, W., Yin, S., Huang, R., Yang, H., Chen, Y., Huang, A., Liu, Y., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.067 · Cited by 201
Antibody tests for identification of current and past infection with SARS-CoV-2
Fox, T., Geppert, J., Dinnes, J., Scandrett, K., Bigio, J., Sulis, G., Hettiarachchi, D., Mathangasinghe, Y., Weeratunga, P., Wickramasinghe, D., et al. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013652.pub2 · Cited by 199
Carsetti, R., Zaffina, S., Piano Mortari, E., Terreri, S., Corrente, F., Capponi, C., Palomba, P., Mirabella, M., Cascioli, S., Palange, P., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.610300 · Cited by 197
Payne, D. C., Smith-Jeffcoat, S. E., Nowak, G., Chukwuma, U., Geibe, J. R., Hawkins, R. J., Johnson, J. A., Thornburg, N. J., Schiffer, J., Weiner, Z., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6923e4 · Cited by 195
SARS-CoV-2 Proteome Microarray for Mapping COVID-19 Antibody Interactions at Amino Acid Resolution
Wang, H., Wu, X., Zhang, X., Hou, X., Liang, T., Wang, D., Teng, F., Dai, J., Duan, H., Guo, S., et al. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00742 · Cited by 193
Clinical characteristics of COVID-19 in children compared with adults in Shandong Province, China
Du, W., Yu, J., Wang, H., Zhang, X., Zhang, S., Li, Q., & Zhang, Z. (2020) · Infection · doi:10.1007/s15010-020-01427-2 · Cited by 191
Ryan, K. A., Bewley, K. R., Fotheringham, S. A., Slack, G. S., Brown, P., Hall, Y., Wand, N. I., Marriott, A. C., Cavell, B. E., Tree, J. A., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20439-y · Cited by 191
Luchsinger, L. L., Ransegnola, B. P., Jin, D. K., Muecksch, F., Weisblum, Y., Bao, W., George, P. J., Rodriguez, M., Tricoche, N., Schmidt, F., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.02005-20 · Cited by 187
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood
Ng, D. L., Goldgof, G. M., Shy, B. R., Levine, A. G., Balcerek, J., Bapat, S. P., Prostko, J., Rodgers, M., Coller, K., Pearce, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18468-8 · Cited by 185
Xie, J., Ding, C., Li, J., Wang, Y., Guo, H., Lu, Z., Wang, J., Zheng, C., Jin, T., Gao, Y., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25930 · Cited by 183
Systems serology detects functionally distinct coronavirus antibody features in children and elderly
Selva, K. J., van de Sandt, C. E., Lemke, M. M., Lee, C. Y., Shoffner, S. K., Chua, B. Y., Davis, S. K., Nguyen, T. H. O., Rowntree, L. C., Hensen, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22236-7 · Cited by 181
Du, H., Dong, X., Zhang, J., Cao, Y., Akdis, M., Huang, P., Chen, H., Li, Y., Liu, G., Akdis, C. A., et al. (2021) · Allergy · doi:10.1111/all.14452 · Cited by 180
Rijkers, G., Murk, J.-L., Wintermans, B., van Looy, B., van den Berge, M., Veenemans, J., Stohr, J., Reusken, C., van der Pol, P., & Reimerink, J. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa463 · Cited by 176
Lu, J., Peng, J., Xiong, Q., Liu, Z., Lin, H., Tan, X., Kang, M., Yuan, R., Zeng, L., Zhou, P., et al. (2020) · eBioMedicine · doi:10.1016/j.ebiom.2020.102960 · Cited by 176
Percivalle, E., Cambiè, G., Cassaniti, I., Nepita, E. V., Maserati, R., Ferrari, A., Di Martino, R., Isernia, P., Mojoli, F., Bruno, R., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.24.2001031 · Cited by 171
Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation
Hurlburt, N. K., Seydoux, E., Wan, Y.-H., Edara, V. V., Stuart, A. B., Feng, J., Suthar, M. S., McGuire, A. T., Stamatatos, L., & Pancera, M. (2020) · Nature Communications · doi:10.1038/s41467-020-19231-9 · Cited by 171
Collecting and evaluating convalescent plasma for COVID‐19 treatment: why and how?
Tiberghien, P., de Lamballerie, X. N., Morel, P., Gallian, P., Lacombe, K., & Yazdanpanah, Y. (2020) · Vox Sanguinis · doi:10.1111/vox.12926 · Cited by 168
Review of Current Advances in Serologic Testing for COVID-19
Espejo, A. P., Akgun, Y., Al Mana, A. F., Tjendra, Y., Millan, N. C., Gomez-Fernandez, C., & Cray, C. (2020) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaa112 · Cited by 167
Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19
Bao, J., Li, C., Zhang, K., Kang, H., Chen, W., & Gu, B. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.06.009 · Cited by 166
D614G mutation of SARS-CoV-2 spike protein enhances viral infectivityPreprint
Hu, J., He, C., Gao, Q., Zhang, G., Cao, X., Long, Q., Deng, H., Huang, L., Chen, J., Wang, K., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.20.161323 · Cited by 162
Minervina, A. A., Komech, E. A., Titov, A., Koraichi, M. B., Rosati, E., Mamedov, I. Z., Franke, A., Efimov, G. A., Chudakov, D. M., Mora, T., et al. (2021) · eLife · doi:10.7554/elife.63502 · Cited by 160
Brochot, É., Demey, B., Touzé, A., Belouzard, S., Dubuisson, J., Schmit, J. L., Duverlie, G., François, C., Castelain, S., & Helle, F. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.584251 · Cited by 159
Worse progression of COVID‐19 in men: Is testosterone a key factor?
Giagulli, V. A., Guastamacchia, E., Magrone, T., Jirillo, E., Lisco, G., Pergola, G. D., & Triggiani, V. (2020) · Andrology · doi:10.1111/andr.12836 · Cited by 155
Clinical performance of different SARS‐CoV‐2 IgG antibody tests
Kohmer, N., Westhaus, S., Rühl, C., Ciesek, S., & Rabenau, H. F. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26145 · Cited by 151
Galson, J. D., Schätzle, S., Bashford-Rogers, R. J. M., Raybould, M. I. J., Kovaltsuk, A., Kilpatrick, G. J., Minter, R., Finch, D. K., Dias, J. C., James, L. K., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.605170 · Cited by 149
Hartman, A. L., Nambulli, S., McMillen, C. M., White, A. G., Tilston‐Lunel, N. L., Albe, J. R., Cottle, E. L., Dunn, M., Frye, L. J., Gilliland, T. H., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008903 · Cited by 145
Klimstra, W. B., Tilston-Lunel, N. L., Nambulli, S., Boslett, J., McMillen, C. M., Gilliland, T., Dunn, M. D., Sun, C., Wheeler, S. E., Wells, A., et al. (2020) · Journal of General Virology · doi:10.1099/jgv.0.001481 · Cited by 137
Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients
Lee, Y.-L., Liao, C.-H., Liu, P., Cheng, C., Chung, M., Liu, C.-E., Chang, S., & Hsueh, P. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.04.019 · Cited by 137
den Hartog, G., Schepp, R. M., Kuijer, M., GeurtsvanKessel, C., van Beek, J., Rots, N., Koopmans, M. P. G., van der Klis, F. R. M., & van Binnendijk, R. S. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa479 · Cited by 137
Zhang, G., Nie, S., Zhang, Z., & Zhang, Z. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa229 · Cited by 135
Zhang, L., Pang, R., Xue, X., Bao, J., Ye, S., Dai, Y., Zheng, Y., Fu, Q., Hu, Z., & Yi, Y. (2020) · Aging · doi:10.18632/aging.103102 · Cited by 133
Flower, B., Brown, J. C., Simmons, B., Moshe, M., Frise, R., Penn, R., Kugathasan, R., Petersen, C., Daunt, A., Ashby, D., et al. (2020) · Thorax · doi:10.1136/thoraxjnl-2020-215732 · Cited by 130
SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease
Wang, P., Liu, L., Nair, M. S., Yin, M. T., Luo, Y., Wang, Q., Yuan, T., Mori, K., Solis, A. G., Yamashita, M., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1823890 · Cited by 122
Humoral Immune Responses in COVID-19 Patients: A Window on the State of the Art
Siracusano, G., Pastori, C., & Lopalco, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01049 · Cited by 122
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France
Fafi-Kremer, S., Bruel, T., Madec, Y., Grant, R., Tondeur, L., Grzelak, L., Staropoli, I., Anna, F., Souque, P., Fernandes-Pellerin, S., et al. (2020) · eBioMedicine · doi:10.1016/j.ebiom.2020.102915 · Cited by 108
Jääskeläinen, A. J., Kekäläinen, E., Kallio‐Kokko, H., Mannonen, L., Kortela, E., Vapalahti, O., Kurkela, S., & Lappalainen, M. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.18.2000603 · Cited by 103
Borremans, B., Gamble, A., Prager, K. C., Helman, S. K., McClain, A. M., Cox, C., Savage, V., & Lloyd‐Smith, J. O. (2020) · eLife · doi:10.7554/elife.60122 · Cited by 101
Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma
Soler, L. F., Daguer, J., Barluenga, S., Vadas, O., Cohen, P., Pagano, S., Yerly, S., Kaiser, L., Vuilleumier, N., & Winssinger, N. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238089 · Cited by 100
The clinical and immunological features of pediatric COVID-19 patients in China
Chen, J., Zhang, Z., Chen, Y., Long, Q., Tian, W., Deng, H., Hu, J., Zhang, X., Pu-Liao, Xiang, J., et al. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.03.008 · Cited by 98
Thompson, C., Grayson, N. E., Paton, R. S., Bolton, J. S., Lourenço, J., Penman, B. S., Lee, L. N., Odon, V., Mongkolsapaya, J., Chinnakannan, S. K., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.42.2000685 · Cited by 98
Long‐term coexistence of SARS‐CoV‐2 with antibody response in COVID‐19 patients
Wang, B., Wang, L., Kong, X., Geng, J., Xiao, D., Ma, C., Jiang, X., & Wang, P. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25946 · Cited by 97
Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2
Anderson, D. E., Tan, C. W., Chia, W. N., Young, B. E., Linster, M., Low, J. G. H., Tan, Y., Chen, M. I.-C., Smith, G. J. D., Leo, Y., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1761267 · Cited by 97
Rosella, L., Bowman, C., Pach, B., Morgan, S., Fitzpatrick, T., & Goel, V. (2016) · Public Health · doi:10.1016/j.puhe.2015.10.027 · Cited by 90
Harvala, H., Robb, M. L., Watkins, N. A., Ijaz, S., Dicks, S., Patel, M., Supasa, P., Dejnirattisai, W., Liu, C., Mongkolsapaya, J., et al. (2020) · Transfusion Medicine · doi:10.1111/tme.12746 · Cited by 89
Varnaitė, R., García, M., Glans, H., Maleki, K. T., Sandberg, J. T., Tynell, J., Christ, W., Lagerqvist, N., Ásgeirsson, H., Ljunggren, H., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000717 · Cited by 84
Vogelzang, E. H., Loeff, F. C., Derksen, N. I. L., Kruithof, S., Heer, P. O., van Mierlo, G. J., Linty, F., Mok, J. Y., van Esch, W. J. E., de Bruin, S., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000767 · Cited by 82
Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients
Choe, P. G., Kang, C. K., Suh, H. J., Jung, J., Kang, E., Lee, S. Y., Song, K., Kim, H. B., Kim, N. J., Park, W. B., et al. (2020) · Emerging infectious diseases · doi:10.3201/eid2610.202211 · Cited by 79
In-depth virological assessment of kidney transplant recipients with COVID-19
Benotmane, I., Gautier-Vargas, G., Wendling, M.-J., Perrin, P., Velay, A., Bassand, X., Bedo, D., Baldacini, C., Sagnard, M., Bozman, D.-F., et al. (2020) · American Journal of Transplantation · doi:10.1111/ajt.16251 · Cited by 79
IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Staines, H. M., Kirwan, D. E., Clark, D. J., Adams, E. R., Augustin, Y. S., Byrne, R. L., Cocozza, M., Cubas-Atienzar, A. I., Cuevas, L. E., Cusinato, M., et al. (2020) · Emerging infectious diseases · doi:10.3201/eid2701.203074 · Cited by 78
Early Viral Clearance and Antibody Kinetics of COVID-19 Among Asymptomatic Carriers
Xiao, T., Wang, Y., Yuan, J., Ye, H., Wei, L., Liao, X., Wang, H., Qian, S., Wang, Z., Liu, L., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.595773 · Cited by 75
Dingens, A. S., Crawford, K. H. D., Adler, A., Steele, S. L., Lacombe, K., Eguia, R. T., Amanat, F., Walls, A. C., Wolf, C. R., Murphy, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18178-1 · Cited by 71
Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression
Shen, L., Wang, C., Zhao, J., Tang, X., Shen, Y., Lu, M., Ding, Z., Huang, C., Zhang, J., Li, S., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1766382 · Cited by 70
Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19
Liu, P., Cai, J., Jia, R., Xia, S., Wang, X., Cao, L., Zeng, M., & Xu, J. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1772677 · Cited by 69
Kreer, C., Zehner, M., Weber, T., Ercanoglu, M. S., Gieselmann, L., Rohde, C., Halwe, S., Korenkov, M., Schommers, P., Vanshylla, K., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.046 · Cited by 67
Prevalence of serum IgG antibodies against SARS-CoV-2 among clinic staff
Schmidt, S. B., Grüter, L., Boltzmann, M., & Rollnik, J. D. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235417 · Cited by 67
Heidepriem, J., Dahlke, C., Kobbe, R., Santer, R., Koch, T., Fathi, A., Seco, B. M. S., Ly, M. L., Schmiedel, S., Schwinge, D., et al. (2021) · Pathogens · doi:10.3390/pathogens10040438 · Cited by 66
Madariaga, M. L. L., Guthmiller, J. J., Schrantz, S. J., Jansen, M. O., Christensen, C., Kumar, M., Prochaska, M., Wool, G. D., Celauro, A. D., Oh, W. H., et al. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13185 · Cited by 65
Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2-Infected Syrian Hamsters
Brocato, R., Principe, L. M., Kim, R. K., Zeng, X.-K., Williams, J. A., Liu, Y.-N., Li, R., Smith, J. M., Golden, J., Gangemi, D., et al. (2020) · Journal of Virology · doi:10.1128/jvi.01683-20 · Cited by 64
Fung, M., Chiu, C. Y., DeVoe, C., Doernberg, S. B., Schwartz, B. S., Langelier, C., Henrich, T. J., Yokoe, D. S., Davis, J. A., Hays, S. R., et al. (2020) · American Journal of Transplantation · doi:10.1111/ajt.16079 · Cited by 63
Humoral Immune Response to SARS-CoV-2
Herroelen, P. H., Martens, G. A., Smet, D. D., Swaerts, K., & Decavele, A.-S. C. (2020) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaa140 · Cited by 62
Sensitivity of anti-SARS-CoV-2 serological assays in a high-prevalence setting
Müller, L., Ostermann, P. N., Walker, A., Wienemann, T., Mertens, A., Adams, O., Andrée, M., Hauka, S., Lübke, N., Keitel, V., et al. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04169-7 · Cited by 61
Marcos‐Jiménez, A., Sánchez‐Alonso, S., Alcaraz‐Serna, A., Esparcia, L., López‐Sanz, C., Sampedro-Nuñez, M. A., Mateu‐Albero, T., Sánchez‐Cerrillo, I., Martínez‐Fleta, P., Gabrie, L., et al. (2020) · European Journal of Immunology · doi:10.1002/eji.202048858 · Cited by 60
Antibody Profiles in Mild and Severe Cases of COVID-19
Liu, Z., Liu, Y., Wan, L., Xiang, T.-X., Le, A., Liu, P., Peiris, M. J. S., Poon, L. L. M., & Zhang, W. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa137 · Cited by 58
Long-term SARS-CoV-2 RNA shedding and its temporal association to IgG seropositivity
Agarwal, V., Venkatakrishnan, A., Puranik, A., Kirkup, C., Lopez-Marquez, A., Challener, D. W., Theel, E. S., O’Horo, J. C., Binnicker, M. J., Kremers, W. K., et al. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00375-y · Cited by 55
Protective humoral immunity in SARS-CoV-2 infected pediatric patients
Zhang, Y., Xu, J., Jia, R., Yi, C., Gu, W., Liu, P., Dong, X., Zhou, H., Shang, B. Z., Cheng, S., et al. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0438-3 · Cited by 54
Sandri, M. T., Azzolini, E., Torri, V., Carloni, S., Pozzi, C., Salvatici, M., Tedeschi, M., Castoldi, M., Mantovani, A., & Rescigno, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-91773-4 · Cited by 50
Kreer, C., Zehner, M., Weber, T., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.12.146290 · Cited by 48
SARS-CoV-2 Viral Load on Admission Is Associated With 30-Day Mortality
Bryan, A. B., Fink, S. L., Gattuso, M. A., Pepper, G., Chaudhary, A., Wener, M. H., Morishima, C., Jerome, K. R., Mathias, P. C., & Greninger, A. L. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa535 · Cited by 47
Yang, H. S., Racine‐Brzostek, S., Lee, W. T., Hunt, D., Yee, J. K., Chen, Z., Kubiak, J. M., Cantu, M. D., Hatem, L., Zhong, E., et al. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.06.004 · Cited by 46
Edouard, S., Colson, P., Melenotte, C., Pinto, F. D., Thomas, L., Scola, B. L., Million, M., Tissot‐Dupont, H., Gautret, P., Stein, A., et al. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04104-2 · Cited by 45
Houlihan, C. F., Vora, N., Byrne, T., Lewer, D., Heaney, J., Moore, D., Matthews, R., Adam, S., Enfield, L., Severn, A., et al. (2020) · medRxiv · doi:10.1101/2020.06.08.20120584 · Cited by 42
Shields, A. M., Faustini, S. E., Pérez-Toledo, M., Jossi, S. E., Allen, J. D., Al‐Taei, S., Backhouse, C., Dunbar, L., Ebanks, D., Emmanuel, B., et al. (2021) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2020-000872 · Cited by 40
Self-citationHuang, J., Mao, T., Li, S., Wu, L., Xu, X., Li, H., Xu, C., Su, F., Dai, J., Shi, J., et al. (2020) · medRxiv · doi:10.1101/2020.04.22.20071258 · Cited by 37
Montenegro, P., Brotons, C., Serrano, J., Fernández, D., Garcia-Ramos, C., Ichazo, B., Lemaire, J., Moral, I., Wienese, R. P., Pitarch, M., et al. (2020) · Family Practice · doi:10.1093/fampra/cmaa096 · Cited by 37
SARS-CoV-2 IgG antibody responses in New York City
Reifer, J., Hayum, N., Heszkel, B., Klagsbald, I., & Streva, V. A. (2020) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2020.115128 · Cited by 35
Antibody Profiling of COVID-19 Patients in an Urban Low-Incidence Region in Northern Germany
Solbach, W., Schiffner, J., Backhaus, I., Burger, D., Staiger, R., Tiemer, B., Bobrowski, A., Hutchings, T., & Mischnik, A. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.570543 · Cited by 33
Cohen, R., Jung, C., Ouldali, N., Sellam, A., Batard, C., Cahn-Sellem, F., Elbez, A., Wollner, A., Romain, O., Corrard, F., et al. (2020) · BMJ Paediatrics Open · doi:10.1136/bmjpo-2020-000887 · Cited by 33
Utility of lateral flow tests in SARS-CoV-2 infection monitorization
Candel, F. J., Viñuela-Prieto, J. M., del Castillo, J. M. G., García, P. B., Saavedra, M. F., Píriz, A. H., Virumbrales, D. J., Canora, J., Sánchez, G. G. D. C., Prieto, R. G., et al. (2020) · Revista Española de Quimioterapia · doi:10.37201/req/052.2020 · Cited by 31
SARS-CoV-2 serology: Test, test, test, but interpret with caution!
Bermingham, W. H., Wilding, T., Beck, S. C., & Huissoon, A. P. (2020) · Clinical Medicine · doi:10.7861/clinmed.2020-0170 · Cited by 29
Self-citationIdentification of immunodominant linear epitopes from SARS-CoV-2 patient plasmaPreprint
Soler, L. F., Daguer, J., Barluenga, S., Cohen, P., Pagano, S., Yerly, S., Kaiser, L., Vuilleumier, N., & Winssinger, N. (2020) · medRxiv · doi:10.1101/2020.06.15.20131391 · Cited by 29
Characterization of 100 sequential SARS‐CoV‐2 convalescent plasma donations
Jungbauer, C., Weseslindtner, L., Weidner, L., Gänsdorfer, S., Farcet, M. R., Reichhart, E., & Kreil, T. R. (2020) · Transfusion · doi:10.1111/trf.16119 · Cited by 29
Danh, K., Karp, D. G., Singhal, M., Tankasala, A., Gebhart, D., Cortez, F. D. J., Tandel, D., Robinson, P. V., Seftel, D., Stone, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31796-1 · Cited by 29
Quantifying antibody kinetics and RNA shedding during early-phase SARS-CoV-2 infectionPreprint
Borremans, B., Gamble, A., Prager, K. C., Helman, S. K., McClain, A. M., Cox, C., Savage, V. M., & Lloyd‐Smith, J. O. (2020) · medRxiv · doi:10.1101/2020.05.15.20103275 · Cited by 27
Wec, A. Z., Wrapp, D., Herbert, A. S., Maurer, D. P., Haslwanter, D., Sakharkar, M., Jangra, R. K., Dieterle, M. E., Lilov, A., Huang, D., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.15.096511 · Cited by 23
IgA MAb blocks SARS-CoV-2 Spike-ACE2 interaction providing mucosal immunityPreprint
Ejemel, M., Li, Q., Hou, S., Schiller, Z. A., Wallace, A., Amcheslavsky, A., Yılmaz, N. K., Toomey, J. R., Schneider, R., Close, B. J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.15.096719 · Cited by 22
Ou, J., Tan, M., He, H., Tan, H., Mai, J., Long, Y., Jiang, X., He, Q., Huang, Y., Li, Y., et al. (2021) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfab003 · Cited by 21
Comparison and application of different immunoassay methods for the detection of SARS‐CoV‐2
He, J., Hu, P., Gao, Y., Zheng, S., Xu, C., Liu, R., Li, F., Li, R., Han, C., An, J., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26187 · Cited by 19
The Production and Clinical Implications of SARS-CoV-2 AntibodiesPreprint
Hu, Q., Cui, X., Liu, X., Peng, B., Jiang, J., Wang, X., Li, Y., Hu, W., Ao, Z., Duan, J., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3576845 · Cited by 18
Gniffke, E. P., Harrington, W. E., Dambrauskas, N., Jiang, Y., Trakhimets, O., Vigdorovich, V. I., Frenkel, L. M., Sather, D. N., & Smith, S. E. P. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa508 · Cited by 17
Buntinx, F., Claes, P. D., Gulikers, M., Verbakel, J. Y. J., Lepeleire, J. D., der Elst, M. V., Elslande, J. V., Ranst, M. A. V., & Vermeersch, P. (2020) · Acta Clinica Belgica · doi:10.1080/17843286.2020.1834285 · Cited by 17
Immunogenic profile of SARS-CoV-2 spike in individuals recovered from COVID-19Preprint
Juno, J. A., Tan, H., Lee, W. S., Reynaldi, A., Kelly, H. G., Wragg, K. M., Esterbauer, R., Kent, H. E., Batten, C. J., Mordant, F. L., et al. (2020) · medRxiv · doi:10.1101/2020.05.17.20104869 · Cited by 15
COVID-19 Serology in Oncology Staff Study: Understanding SARS-CoV-2 in the Oncology Workforce
Favara, D. M., Cooke, A., Döffinger, R., Houghton, S., Budriunaite, I., Bossingham, S., McAdam, K., Corrie, P. G., & Ainsworth, N. L. (2020) · Clinical Oncology · doi:10.1016/j.clon.2020.07.015 · Cited by 14
Cross-sectional IgM and IgG profiles in SARS-CoV-2 infectionPreprint
Ozturk, T. T., Howell, C., Benameur, K., Ramonell, R. P., Cashman, K. S., Pirmohammed, S., Bassit, L., Roback, J. D., Marconi, V. C., Schinazi, R. F., et al. (2020) · medRxiv · doi:10.1101/2020.05.10.20097535 · Cited by 13
Duan, L., Zhang, S., Guo, M., Zhou, E., Fan, J., Wang, X., Wang, L., Wu, F., & Jin, Y. (2020) · medRxiv · doi:10.1101/2020.06.18.20134619 · Cited by 13
Lou, Y., Zhao, W., Wei, H., Chu, M. G., Chao, R., Yao, H., Su, J., Li, Y., Li, X., Cao, Y., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.06.137513 · Cited by 9
Dobi, A., Frumence, É., Rakoto, M. L., Lebeau, G., Vagner, D., Anne-Laure, S. S., Giry, C., Septembre‐Malaterre, A., Jaffar‐Bandjee, M., Raffray, L., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123847 · Cited by 8
Bwire, G. M., & Njiro, B. J. (2020) · medRxiv · doi:10.1101/2020.06.09.20127118 · Cited by 4
Minervina, A. A., Komech, E. A., Titov, A., Koraichi, M. B., Rosati, E., Mamedov, I. Z., Franke, A., Efimov, G. A., Chudakov, D. M., Mora, T., et al. (2020) · doi:10.7554/elife.63502.sa2 · Cited by 3
Cited by
T cell response to SARS-CoV-2 infection in humans: A systematic review
Shrotri, M., van Schalkwyk, M. C. I., Post, N., Eddy, D., Huntley, C., Leeman, D., Rigby, S., Williams, S. V., Bermingham, W. H., Kellam, P., et al. (2021) · PLOS ONE · doi:10.1371/journal.pone.0245532 · Cited by 350
Self-citationCorrelates of protection against SARS‐CoV‐2 infection and COVID‐19 disease
Goldblatt, D., Alter, G., Crotty, S., & Plotkin, S. A. (2022) · Immunological Reviews · doi:10.1111/imr.13091 · Cited by 298
Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis
Chen, X., Chen, Z., Azman, A. S., Deng, X., Sun, R., Zhao, Z., Zheng, N., Chen, X., Lu, W., Zhuang, T., et al. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(21)00026-7 · Cited by 239
Comprehensive, Comparative Evaluation of 35 Manual SARS-CoV-2 Serological Assays
Dimech, W., Curley, S., Subissi, L., Ströher, U., Perkins, M. D., & Cunningham, J. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.05101-22 · Cited by 4
“Early in the pandemic, the utility of SARSCoV-2 serology testing was unknown but was used due to the lack of inexpensive point-of-care testing options and the long turnaround times for molecular diagnostics (7, 9, 10).”
Background
Metadata
- Authors
- Post, N., Eddy, D., Huntley, C., van Schalkwyk, M. C. I., Shrotri, M., Leeman, D., Rigby, S., Williams, S. V., Bermingham, W. H., Kellam, P., Maher, J., Shields, A. M., Amirthalingam, G., Peacock, S. J., & Ismail, S. A.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-12-31
- Volume
- 15
- Issue
- 12
- Pages
- e0244126
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W4241518937
- Cited by
- 374
- References
- 179
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.